SEMINARS IN THROMBOSIS, THROMBOLYSIS, AND VASCULAR BIOLOGY .2. COAGULATION AND THROMBOSIS

被引:2
作者
BECKER, RC
机构
[1] Thrombosis Research Center, University of Massachusetts Medical School, Worcester, MA
关键词
COAGULATION; THROMBOSIS; CARDIOVASCULAR DISEASE;
D O I
10.1159/000174792
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The hemostatic mechanism is a critical component of a normally functioning circulatory system, preventing life-threatening hemorrhage and assisting in the maintenance of vascular integrity. For longer than half a century, however, nonphysiological intravascular coagulation and thrombosis have been recognized as playing central roles in cardiovascular morbidity and mortality. In order to provide a conceptual framework for the use of antithrombotic therapy, the pathogenetic mechanisms underlying thrombotic events must be clearly understood. The purpose of this review is to define these mechanisms, and discuss the use of anticoagulants in both the prevention and treatment of cardiovascular diseases.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 62 条
[1]   ABNORMAL-BLOOD PATHWAYS IN LEFT-VENTRICULAR CAVITY IN ACUTE MYOCARDIAL-INFARCTION - EXPERIMENTAL-OBSERVATIONS WITH SPECIAL REFERENCE TO REGIONAL WALL MOTION ABNORMALITY AND HEMOSTASIS [J].
BEPPU, S ;
IZUMI, S ;
MIYATAKE, K ;
NAGATA, S ;
PARK, YD ;
SAKAKIBARA, H ;
NIMURA, Y .
CIRCULATION, 1988, 78 (01) :157-164
[2]   EFFECT OF HEPARIN ON CORONARY ARTERIAL PATENCY AFTER THROMBOLYSIS WITH TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION [J].
BLEICH, SD ;
NICHOLS, TC ;
SCHUMACHER, RR ;
COOKE, DH ;
TATE, DA ;
TEICHMAN, SL .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (20) :1412-1417
[3]   CHARACTERISTICS AND PROGNOSIS OF LONE ATRIAL-FIBRILLATION - 30-YEAR FOLLOW-UP IN THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
ABBOTT, RD ;
KANNEL, WB ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (24) :3449-3453
[4]  
BRESHNAHAN DR, 1988, J AM COLL CARDIOL, V6, P285
[5]   ENHANCEMENT OF THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PRETREATMENT WITH HEPARIN [J].
CERCEK, B ;
LEW, AS ;
HOD, H ;
YANO, J ;
REDDY, NKN ;
GANZ, W .
CIRCULATION, 1986, 74 (03) :583-587
[6]  
CHESEBRO JH, 1985, ANNU REV MED, V36, P579
[7]   LEVELS OF 3 HEMOSTATIC FACTORS IN RELATION TO SERUM-LIPIDS - MONOCYTE PROCOAGULANT ACTIVITY, TISSUE PLASMINOGEN-ACTIVATOR, AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CRUTCHLEY, DJ ;
MCPHEE, GV ;
TERRIS, MF ;
CANOSSATERRIS, MA .
ARTERIOSCLEROSIS, 1989, 9 (06) :934-939
[8]   A NOVEL FORM OF FACTOR-VII IN PLASMA FROM MEN AT RISK FOR CARDIOVASCULAR-DISEASE [J].
DALAKER, K ;
HJERMANN, I ;
PRYDZ, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (02) :315-322
[9]  
DAVISON R, 1987, CIRCULATION, V76, P102
[10]  
DEBAKEY ME, 1978, ATHEROSCLER REV, P1